BSE · SKYBIOTECH
SKYBIOTECH HEALTHCARE LIMITED
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#3,982
of 5,004 stocks
🏆 New peak
▲ 191W
Peak #3,982 · 01 Oct 2026
SKYBIOTECH HEALTHCARE LIMITED is a microcap company in the Capital Goods space and has a subdued return on equity, remains firmly promoter-controlled, with promoters holding 63%, and is growing revenue modestly.
Market Cap
22.25 Cr
P/E Ratio
17.34
P/B Ratio
2.40
ROE
-12.07%
ROCE
-9.40%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 49.31 L | 1.83 Cr | 96.27 L | 1.92 Cr |
| Net Profit | -57.36 L | -30.38 L | -48.47 L | -30.96 L |
| EPS | 2.56 | 2.96 | 1.29 | 1.29 |
| Operating Profit | -56.99 L | -84.87 L | -48.03 L | -30.49 L |
Shareholding pattern
Promoter
63.48%
Public
36.52%
PUBLIC BREAKDOWN
Individuals
34.69%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
No corporate actions on record for this stock.
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.